The growing field of biological therapy relies heavily on recombinant growth factor technology, and a precise understanding of individual profiles is paramount for optimizing experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, Adipose-Derived Stem Cells (ADSCs) and IL-3 reveals not